Alterations in Purinoceptor Expression in Human Long Saphenous Vein during Varicose Disease
Authors:
- D.M. BakerDBD.M. Baker
- M. TurmaineMTM. Turmaine
- G. BurnstockGBG. Burnstock
- 1 February 2007
- journal article
- Published by Elsevier in European Journal of Vascular and Endovascular Surgery
- Vol. 33 (2) , 239-250
Abstract
No abstract availableKeywords
This publication has 42 references indexed in Scilit:
- Introduction: P2 ReceptorsCurrent Topics in Medicinal Chemistry, 2004
- Characterization of the UDP-glucose receptor (re-named here the P2Y14 receptor) adds diversity to the P2Y receptor familyTrends in Pharmacological Sciences, 2003
- Involvement of purinergic signaling in cardiovascular diseasesDrug News & Perspectives, 2003
- Purinergic Signaling and Vascular Cell Proliferation and DeathArteriosclerosis, Thrombosis, and Vascular Biology, 2002
- Smooth muscle cell modulation and cytokine overproduction in varicose veins. Anin situ studyThe Journal of Pathology, 2001
- The P2Y 12 receptor as a therapeutic target in cardiovascular diseasePlatelets, 2001
- Smooth Muscle Changes in Varicose Veins: An Ultrastructural StudyJournal of Smooth Muscle Research, 2001
- Adenosine 5′‐triphosphate and neuropeptide Y are co‐transmitters in conjunction with noradrenaline in the human saphenous veinBritish Journal of Pharmacology, 1999
- Integration of Factors Controlling Vascular ToneAnesthesiology, 1993
- Adenosine and the treatment of supraventricular tachycardiaThe American Journal of Medicine, 1992